Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 15, 2026

Is It Time To Reassess UPS (UPS) After Recent Parcel Demand Headlines And Mixed Returns?

View original at finance.yahoo.com
“For United Parcel Service, the model used is a 2 Stage Free Cash Flow to Equity approach, based on Free Cash Flow in the last twelve months of about $4.3b.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Recent headlines have focused on UPS as a bellwether for parcel volumes, labor costs and broader freight demand

    60% confidence
  • UPS shares trade at about a 37.8% discount to intrinsic value based on DCF analysis

    60% confidence
  • UPS currently scores 5 out of 6 on Simply Wall St's valuation checks

    60% confidence
  • Analysts project UPS annual Free Cash Flow to reach $9.6 billion by 2035

    60% confidence
  • UPS Free Cash Flow is estimated at $7.6 billion in 2029

    60% confidence
  • UPS Free Cash Flow is estimated at $6.1 billion in 2026

    60% confidence
  • United Parcel Service is undervalued by 37.8% according to DCF analysis

    60% confidence

Data points we hold from this source

United Parcel Service · free cash flow4.3 USD
United Parcel Service · intrinsic value per share166.04 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com